Journals By Industry - Prescription Drugs

HIGHLAND PARK, N.J., Feb. 1, 2012 (SEND2PRESS NEWSWIRE) -- 2012 marks an important milestone for Belvidere Pharmacy. It opened new doors in its new hometown of Highland Park. When owner and President Shara...

The company has also announced the assignment of US co-promotion rights to AQUORAL, an FDA-cleared, prescription-only spray for the treatment of Xerostomia, or the medical term for dry mouth due to a lack...

Health care reform is projected to cover 30 million more people, with health insurance--and overwhelm the nation's doctors. That's where Walgreen Co. thinks. it can help. Executives of the Illinois-based company, including its...

NovaDel Pharma, Inc., a specialty pharmaceutical company, has terminated license agreement with Talon Therapeutics, Inc. (formerly Hana Biosciences, Inc. ) and Par Pharmaceutical Companies, Inc., for Zensana. Talon is a biopharmaceutical company, while...

NovaDel Pharma, Inc., a specialty pharmaceutical company, has terminated its license agreements with Talon Therapeutics, Inc. (formerly Hana Biosciences, Inc. ) and Par Pharmaceutical Companies, Inc., for Zensana. Talon is a biopharmaceutical company,...

Something doesn't add up about Arcadia Resources Inc.'s agreement to sell its pharmacy business for a low price of $2 million, according to many of the Indianapolis company's investors. That sentiment has left...

PRINCETON, N.J. & WILMINGTON, Del. -- Bristol-Myers Squibb Company (NYSE: BMY) and AstraZeneca (NYSE: AZN) today announced that the U.S. Food and Drug Administration (FDA) has issued a complete response letter regarding the...

BALERNA, Switzerland -- APR Applied Pharma Research s.a. ("APR"), Labtec GmbH ("Labtec") and Norgine BV ("Norgine") announce the signature of an exclusive licensing agreement under which Norgine will market and distribute Setofilm[TM] Ondansetron...

BRIDGEWATER, N.J. -- NovaDel Pharma Inc. (OTCBB: NVDL), a specialty pharmaceutical company that develops oral spray formulations of marketed pharmaceutical products, today announced that, as previously disclosed, it is continuing to explore various...

AMITYVILLE, N.Y. -- Hi-Tech Pharmacal Co., Inc. (NASDAQ:HITK), a specialty pharmaceuticals company, announced today that it has acquired marketing and distribution rights to a topical wound gel product from Glycobiosciences , Inc. The...

DULUTH, Ga. -- PRIUM released a new white paper, "Legacy Cleanup, Texas Style" on the Texas Closed Formulary (TCF), which requires preauthorization of any drug that has an Official Disability Guidelines (ODG) status...

Gov. Andrew Cuomo, in his executive budget proposal released yesterday, included a plan known as SafeRX, designed to help patients understand prescriptions, even if they aren't proficient in English or have limited vision....

DUBLIN -- Research and Markets (http://www.researchandmarkets.com/research/a40950/market_and_product) has announced the addition of the "Market and Product Forecasts: Antidyslipidemics - Set for the impact of generic Lipitor" report to their offering. The industry is bracing...

DUBLIN -- Research and Markets (http://www.researchandmarkets.com/research/a21943/pagets_disease_of) has announced the addition of GlobalData 's new report "Paget's Disease of Bone (PDB) Therapeutics - Pipeline Assessment and Market Forecasts to 2018" to their offering. PDB...

WINNIPEG, Canada -- The Canadian International Pharmacy Association (CIPA) today announced its member pharmacies will participate in the January 18 blackout in protest of Congress' proposed anti-piracy legislation. The Stop Online Piracy Act...

Convenient TransChoice Plus ID/debit card speeds up reimbursement; deep discounts stretch healthcare dollars LITTLE ROCK, Ark. -- Transamerica Employee Benefits, formerly known as Transamerica Worksite Marketing, today announced the launch of a new...

ePharma Consumer ([R] ) Study Reveals New Trends around How Consumers Interact with Pharma, Including Customer Service Options, Patient Education, and Pharma Websites - Webinar January 25 at 2pm ET NEW YORK --...

JERUSALEM -- Teva Pharmaceutical Industries Ltd. (NASDAQ: TEVA) announced today that it will release its fourth quarter and full year 2011 financial results on Wednesday, February 15, 2012. Teva will host a conference...

HALLE, Germany -- Scil Proteins, a private biotech company specialized in the research, development and production of recombinant proteins, announced today that it has signed a supply agreement with Actavis, one of the...